Multicenter Trial of Prednisone in Alzheimer's Disease

Completed · Phase 3

Conditions studied: Alzheimer Disease

In brief

This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.

Key facts

Study ID

NCT00000178

Run by

National Institute on Aging (NIA)

Last updated by the study team

2005-06-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with Alzheimer's disease who are in stable medical condition

You may not qualify if…

• Patients with diabetes or severe osteoporosis

Where it is running

• University of Alabama, Birmingham — Birmingham, Alabama, United States
• University of Southern California — Los Angeles, California, United States
• University of California, San Diego — San Diego, California, United States
• Mayo Clinic Jacksonville — Jacksonville, Florida, United States
• University of Miami — Miami, Florida, United States
• University of South Florida — Tampa, Florida, United States
• Indiana University Alzheimer's Center — Indianapolis, Indiana, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Washington University — St Louis, Missouri, United States
• New York University Medical Center — New York, New York, United States
• Mount Sinai Medical Center — New York, New York, United States
• Columbia Presbyterian Medical Center — New York, New York, United States
• University of Rochester — Rochester, New York, United States
• Burke Medical Research Institute — White Plains, New York, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States
• University of Texas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.